Best Growth Stocks To Buy

In this article:

High growth companies such as Beadell Resources and Corporate Travel Management has a positive future outlook in terms of their returns, profitability and cash flows. The prospects of these companies tend to outperform others, regardless of how the stock market is generally doing. Analysing the most recent financial data, I’ve created a list of companies that compare favourably in all criteria, making them potentially good additions to your portfolio.

Beadell Resources Limited (ASX:BDR)

Beadell Resources Limited operates as a gold producer in Brazil and Australia. Beadell Resources is currently led by CEO Lawrence Jackson. The company currently has a market cap of AUD A$102.37M, putting it in the small-cap category

BDR’s projected future profit growth is an exceptional 85.06%, with an underlying 26.86% growth from its revenues expected over the upcoming years. Though some cost-cutting activities may artificially inflate margins, it appears that this isn’t solely the case here, as profit growth is also coupled with high top-line expansion. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 8.20%. BDR’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Could this stock be your next pick? Take a look at its other fundamentals here.

ASX:BDR Future Profit Apr 27th 18
ASX:BDR Future Profit Apr 27th 18

Corporate Travel Management Limited (ASX:CTD)

Corporate Travel Management Limited, a travel management solutions company, manages the purchase and delivery of travel services for the corporate market worldwide. Formed in 1994, and currently lead by Jamie Pherous, the company provides employment to 2,200 people and with the company’s market cap sitting at AUD A$2.51B, it falls under the mid-cap category.

An outstanding 20.25% earnings growth is forecasted for CTD, driven by an underlying sales growth of 27.12% over the next few years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 22.14%. CTD’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Should you add CTD to your portfolio? I recommend researching its fundamentals here.

ASX:CTD Future Profit Apr 27th 18
ASX:CTD Future Profit Apr 27th 18

Pro Medicus Limited (ASX:PME)

Pro Medicus Limited provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions worldwide. Established in 1983, and currently lead by Sam Hupert, the company size now stands at 69 people and with the company’s market cap sitting at AUD A$793.87M, it falls under the small-cap category.

PME is expected to deliver a buoyant earnings growth over the next couple of years of 36.36%, bolstered by an equally impressive revenue growth of 55.70%. It appears that PME’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 40.28%. PME’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Could this stock be your next pick? Take a look at its other fundamentals here.

ASX:PME Future Profit Apr 27th 18
ASX:PME Future Profit Apr 27th 18

For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.

Advertisement